The vaccine is approved for emergency use. The FDA had set an April 1 deadline for a decision on whether to grant a normal, full approval, the WSJ reported. Write to [email protected] ...
Novavax (NasdaqGS:NVAX) recently experienced a significant decline of 21% over the past week, coinciding with leadership changes, including the retirement of longtime Chairman James Young and the ...
Vaccine stocks are down after the health agency's top immunization official announced the move Monday, citing Secretary ...
We recently curated a list of 11 High-Risk High-Reward Growth Stocks To Buy Now. Here, we take a detailed look at Novavax, ...